Drugs / Meilian Fuxin Solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07353671 | Mar → Dec 2026 expected | radiodermatitis | West China Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meilian Fuxin Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07353671 ↗ |
| Route | Topical | “Topical application of Periplaneta americana-derived Meilian Fuxin Solution” NCT07353671 ↗ |